These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1835749)

  • 21. The uses of modern technologies: problems and perspectives for industrialized and developing countries.
    Banta D
    Bull Pan Am Health Organ; 1984; 18(2):139-50. PubMed ID: 6487871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technology assessment in medicine: methods, status and trends.
    Hendee WR
    Med Prog Technol; 1991; 17(2):69-75. PubMed ID: 1835752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Technology decision making. A constructive approach to planning and acquisition will require a paradigm shift.
    Berkowitz DA; Swan MM
    Health Prog; 1993; 74(1):42-7. PubMed ID: 10123568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health care technology assessment and adoption: a case study.
    Veluchamy S; Alder HC
    Hosp Technol Ser; 1989 May; 8(13):1-12. PubMed ID: 10304477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health technology assessment in Australia: the role of AHTAC. Australian Health Technology Advisory Committee.
    Kearney B; Willis E
    Australas Phys Eng Sci Med; 1997 Dec; 20(4):193-7. PubMed ID: 9503689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Joint project of the International Network of Agencies for Health Technology Assessment--Part 2: Managing the diffusion of positron emission tomography with health technology assessment.
    Adams EJ; Almazán C; Mørland B; Bradbury I; King R; Rheinberger P
    Int J Technol Assess Health Care; 2006; 22(2):149-54. PubMed ID: 16571189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technology management: case study of an integrated health system.
    Dahl DH; McFarlan TK
    Hosp Technol Ser; 1994 Dec; 13(17):1-30. PubMed ID: 10139509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment and regulation of health care technology. The Dutch experience.
    Boer A
    Int J Technol Assess Health Care; 1999; 15(4):638-48. PubMed ID: 10645105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New technology planning and approval: critical factors for success.
    Haselkorn A; Rosenstein AH; Rao AK; Van Zuiden M; Coye MJ
    Am J Med Qual; 2007; 22(3):164-9. PubMed ID: 17485557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Big ticket health technology: is rational utilization possible?
    Johansen KS; Racoveanu NT
    Med Prog Technol; 1991; 17(2):85-91. PubMed ID: 1835754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A decade to the Israeli Center for Technology Assessment in Health Care.
    Tamir O; Shemer J; Shani M; Vaknin S; Siebzehner MI
    Isr Med Assoc J; 2008 Dec; 10(12):901-5. PubMed ID: 19160954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Priority setting for horizon scanning of new health technologies in Denmark: views of health care stakeholders and health economists.
    Douw K; Vondeling H; Oortwijn W
    Health Policy; 2006 May; 76(3):334-45. PubMed ID: 16081185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there an alternative to a National Health Board for Technology Assessment?
    Lerner JC
    Med Interface; 1994 Jun; 7(6):123-6, 132. PubMed ID: 10135316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How intravenous immunoglobulin is used in clinical practice: audits of two Sydney teaching hospitals.
    Lin MW; Kirkpatrick PE; Riminton DS
    Intern Med J; 2007 May; 37(5):308-14. PubMed ID: 17504278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The assessment process: a microscopic view.
    Murphy JR
    Med Prog Technol; 1991; 17(2):77-83. PubMed ID: 1835753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moving low value care lists into action: prioritizing candidate health technologies for reassessment using administrative data.
    Soril LJJ; Seixas BV; Mitton C; Bryan S; Clement FM
    BMC Health Serv Res; 2018 Aug; 18(1):640. PubMed ID: 30111308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conceptual modeling for Prospective Health Technology Assessment.
    Gantner-Bär M; Djanatliev A; Prokosch HU; Sedlmayr M
    Stud Health Technol Inform; 2012; 180():33-7. PubMed ID: 22874147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation in a disconnected healthcare system: problems and suggested solutions from the Australian HTA review.
    Gallego G; Harris A
    Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):615-7. PubMed ID: 21155692
    [No Abstract]   [Full Text] [Related]  

  • 39. Health Technology Assessment in Australia: The Pharmaceutical Benefits Advisory Committee and Medical Services Advisory Committee.
    Kim H; Byrnes J; Goodall S;
    Value Health Reg Issues; 2021 May; 24():6-11. PubMed ID: 33429153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health care technology in Australia.
    Hailey D
    Health Policy; 1994; 30(1-3):23-72. PubMed ID: 10139492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.